Company
Every investor coverage indicates participated in a round AstraZeneca raised.
Companies AstraZeneca acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Pascal Soriot | CEO | Startup Daily, SmartCompany |
Stories naming AstraZeneca. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Brisbane radiopharmaceutical developer AdvanCell has closed an oversubscribed Series D round, led by Ally Bridge Group and Alpha Wave with several institutional investors returning, to fund late-stage prostate cancer trials and US manufacturing.
Weekly agrifoodtech roundup: raises by Everytable, Bluu Seafood, Hyfe, eFishery, eAgronom and Stacked Farm; fund closes by Omnivore, Innova Memphis and Joyful Ventures; Meituan buys Light Year; Vindara sold; Honest AgTech bankrupt.
Cascade has landed a $40 million Series A led by Telescope Partners, with Five V and Carthona joining; proceeds follow a $5 million seed and target product and global growth.
Cascade, a Sydney strategy-execution software company, has closed a $40 million Series A led by Telescope Partners with Five V and Carthona Capital, to fund product development and expansion into North America and Europe.
Also SmartCompany·Techboard
SAP announced its intention to acquire a majority stake in working capital management provider Taulia, which will keep its brand and CEO, while J.P. Morgan maintains its alliance and equity stake. Financial terms undisclosed.